Clinical Trial

Plasma Proteomics Study of End-Stage Liver Disease Patients Based on Olink Technology

Name: Plasma Proteomics Study of End-Stage Liver Disease Patients Based on Olink Technology — clinical trial record (NCT06865898)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting

View on ClinicalTrials.gov →

Summary

Exploring Early Biomarkers of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure Using Olink Proteomics

Trial Details

NCT Number	NCT06865898
Lead Sponsor	Qilu Hospital of Shandong University
Conditions	HBV Related Acute-on-chronic Liver Failure
Enrollment	58 participants
Start Date	2023-03-01
Primary Completion	2025-03 (estimated)
Study Completion	2025-03 (estimated)
Updated on ClinicalTrials.gov	2025-03-10